Use of rpn2 gene expression inhibitor

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/713 (2006.01) A61K 31/337 (2006.01) A61K 45/06 (2006.01) A61K 47/42 (2006.01) A61P 35/00 (2006.01) A61P 35/02 (2006.01) A61P 43/00 (2006.01) A61K 48/00 (2006.01)

Patent

CA 2655355

Disclosed is use of an RPN2 gene expression inhibitor as a cancer cell proliferation inhibitor. If required, the cancer cell proliferation inhibitor may further contain an agent having an anti-cancer activity. If required, the cancer cell proliferation inhibitor may be administered together with atelocollagen. Also disclosed is an anti-cancer agent comprising the cancer cell proliferation inhibitor.

La présente invention concerne l'utilisation d'un inhibiteur de l'expression du gène RPN2 pour inhiber la prolifération des cellules cancéreuses. Si nécessaire, l'inhibiteur de la prolifération des cellules cancéreuses peut contenir en outre un agent ayant une activité anticancéreuse. Si nécessaire, l'inhibiteur de la prolifération des cellules cancéreuses peut être administré en même temps que de l'atélocollagène. L'invention concerne également un agent anticancéreux comprenant l'inhibiteur de la prolifération des cellules cancéreuses.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Use of rpn2 gene expression inhibitor does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of rpn2 gene expression inhibitor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of rpn2 gene expression inhibitor will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1626112

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.